Abstract: The invention provides novel reagents, kits, and methods for diagnosis of predisposition to left ventricular heart failure, based on analysis of polymorphic variants of the genomic nucleic acid set forth in SEQ ID NO:1
Type:
Grant
Filed:
August 3, 2001
Date of Patent:
March 4, 2003
Assignee:
Sequenom-Gemini Limted
Inventors:
Maria Kristina Andersson, Lars Gunnar Ture Berglund, Rikard Henry Reneland, Gail Isabel Reid Adam